Supplemental Table 3 from Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2− Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7
Year: 2024
Type: supplementary-materials
Abstract: Supplemental Table 3. Multivariable analysis of treatment benefit by subtype
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4391882172